by Waylon Wright | Mar 31, 2017
Diagnostic and lab-developed test (LDT) regulations could soon receive a significant overhaul. RAPS reported this week that a bipartisan duo, Rep. Larry Buchson, M.D. (R-IN) and Diana DeGetter (D-CO), released a discussion draft for a bill proposing a new path for the...
by Waylon Wright | Mar 29, 2017
The 21st Century Cures Act, signed into law on December 13, 2016, includes several provisions related to regenerative medicine. Regenerative medicine covers a wide range of innovative products including cell therapies, therapeutic tissue engineering products, human...
by Waylon Wright | Mar 23, 2017
Last Friday, the US Food and Drug Administration (FDA) announced it will not implement its final rule specifying when tobacco products are regulated as medical products until March of 2018, RAPS reports. The delay comes in the wake of a petition presented by...
by Waylon Wright | Mar 22, 2017
Perhaps you haven’t noticed the flurry of articles written about Indianapolis lately. Journalists and analysts continue to praise Indianapolis’ airport, food scene, and tourism. These are praiseworthy aspects of Indiana’s growing capital, but a strong, diverse job...
by Waylon Wright | Mar 14, 2017
Regulatory Affairs Professionals Society (RAPS) is seeking qualified individuals to serve on the RAPS board of directors for the 2018-2020 term. RAPS, the largest global organization of and for those involved with the regulation of healthcare and related products...
